Literature DB >> 28455951

Chronic viral hepatitis and its association with liver cancer.

Thomas Tu1, Sandra Bühler1, Ralf Bartenschlager1.   

Abstract

Chronic infection with hepatitis viruses represents the major causative factor for end-stage liver diseases, including liver cirrhosis and primary liver cancer (hepatocellular carcinoma, HCC). In this review, we highlight the current understanding of the molecular mechanisms that drive the hepatocarcinogenesis associated with chronic hepatitis virus infections. While chronic inflammation (associated with a persistent, but impaired anti-viral immune response) plays a major role in HCC initiation and progression, hepatitis viruses can also directly drive liver cancer. The mechanisms by which hepatitis viruses induce HCC include: hepatitis B virus DNA integration into the host cell genome; metabolic reprogramming by virus infection; induction of the cellular stress response pathway by viral gene products; and interference with tumour suppressors. Finally, we summarise the limitations of hepatitis virus-associated HCC model systems and the development of new techniques to circumvent these shortcomings.

Entities:  

Keywords:  DNA integration; ER stress; hepatitis B virus; hepatitis C virus; hepatitis Delta virus; hepatocellular carcinoma; liver cancer; metabolic reprogramming; mutagenesis; oxidative stress; steatosis

Mesh:

Year:  2017        PMID: 28455951     DOI: 10.1515/hsz-2017-0118

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  34 in total

1.  Advanced Hepatitis C Virus Replication PDE Models within a Realistic Intracellular Geometric Environment.

Authors:  Markus M Knodel; Paul Targett-Adams; Alfio Grillo; Eva Herrmann; Gabriel Wittum
Journal:  Int J Environ Res Public Health       Date:  2019-02-12       Impact factor: 3.390

2.  Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.

Authors:  Wei Tu; Jin Gong; Dean Tian; Zhijun Wang
Journal:  Dig Dis Sci       Date:  2019-05-30       Impact factor: 3.199

3.  The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis.

Authors:  Soheil Hassanipour; Majid Mohammadzadeh; Fariborz Mansour-Ghanaei; Mohammad Fathalipour; Farahnaz Joukar; Hamid Salehiniya; Elham Abdzadeh; Ali Akbar Samadani; Hossein-Ali Nikbakht; Morteza Arab-Zozani
Journal:  J Gastrointest Cancer       Date:  2019-06

4.  Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in Germany.

Authors:  Sven H Loosen; David Schöler; Mark Luedde; Johannes Eschrich; Tom Luedde; Karel Kostev; Christoph Roderburg
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-22       Impact factor: 4.322

Review 5.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

6.  Identification of Key Genes for Hepatitis Delta Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.

Authors:  Cheng Zhang; Shan Wu; Xiao-Dong Yang; Hui Xu; Tai Ma; Qi-Xing Zhu
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

7.  Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer.

Authors:  Renyuan Gao; Yefei Zhu; Cheng Kong; Kai Xia; Hao Li; Yin Zhu; Xiaohui Zhang; Yongqiang Liu; Hui Zhong; Rong Yang; Chunqiu Chen; Nan Qin; Huanlong Qin
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

8.  Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma via Suppression of Pro-Inflammatory Immune Responses.

Authors:  Sang R Lee; Jong Geol Lee; Jun H Heo; Seong Lae Jo; Jihoon Ryu; Globinna Kim; Jung-Min Yon; Myeong Sup Lee; Geun-Shik Lee; Beum-Soo An; Hyun-Jin Shin; Dong-Cheol Woo; In-Jeoung Baek; Eui-Ju Hong
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 9.  Polyphenols as Promising Drugs against Main Breast Cancer Signatures.

Authors:  María Losada-Echeberría; María Herranz-López; Vicente Micol; Enrique Barrajón-Catalán
Journal:  Antioxidants (Basel)       Date:  2017-11-07

10.  Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status.

Authors:  Jin Bong Choi; Eun Joo Lee; Kyung-Do Han; Sung-Hoo Hong; U-Syn Ha
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.